ClinConnect ClinConnect Logo
Search / Trial NCT06665763

The Lactate Project: Investigating the Impact of Lactate to Preserve Vital Organ Blood Supply and Function in Heart and Brain

Launched by UNIVERSITY OF AARHUS · Oct 29, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Human Metabolism Substrate Utilization Cerebral Blod Flow Cardiac Metabolism Cerebral Metabolism Cardiac Perfusion Glucose Metabolism Lipid Metabolism Lactate Utilization

ClinConnect Summary

The Lactate Project is a clinical trial that aims to understand how increasing levels of lactate in the blood affect the heart and brain. Researchers believe that when lactate levels rise, it could change how the heart and brain use other energy sources, like glucose. Specifically, they think that higher lactate might reduce the brain's use of glucose while increasing blood flow to the brain. For the heart, they expect that increased lactate will lower the uptake of certain fats and glucose, but improve blood flow to the heart muscle.

This study is looking for participants aged 55 to 75 years, including both men and postmenopausal women, with a body mass index (BMI) between 20 and 35. To participate, individuals must sign a consent form and pass a health screening to ensure they don’t have serious medical issues. Participants can expect to undergo some tests and evaluations related to their heart and brain health during the study. It’s important to note that people with certain health conditions, recent blood donations, or those who smoke or have substance abuse issues cannot participate. If you're interested, keep an eye out for more information as the trial is not yet recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 55-75 years
  • 2. Male or postmenopausal female
  • 3. BMI 20-35 kg/m2
  • 4. Signed informed consent form
  • Exclusion Criteria:
  • 1. Clinically significant heart, lung, kidney, kidney, liver, endocrine or malignant disease basedon information obtained during an initial screening visit as well as blood samples and an ECG.
  • 2. Blood donation within the last 3 months
  • 3. Smoking
  • 4. Alcohol- or substance abuse
  • 5. Participation in other clinical trials involving ionized radiation within the last 6 months
  • 6. Claustrophobia

About University Of Aarhus

The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.

Locations

Aarhus, N, Denmark

Aarhus, N, Denmark

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported